| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | N A Berger | |
| P2860 | cites work | Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 | Q29555853 |
| Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults | Q34106444 | ||
| Race, age, and obesity disparities in adult physical activity levels in breast cancer patients and controls | Q34211120 | ||
| Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing | Q34459665 | ||
| Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial | Q34524632 | ||
| Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline | Q34637194 | ||
| Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA). | Q34856664 | ||
| Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. | Q35044358 | ||
| Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults | Q36661808 | ||
| Exercise in adult and pediatric hematological cancer survivors: an intervention review. | Q37735697 | ||
| Trimming the fat: obesity and hematopoietic cell transplantation | Q38056012 | ||
| Chemotherapy dosing in overweight and obese patients with cancer | Q38121735 | ||
| Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee. | Q38181810 | ||
| Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant | Q43500413 | ||
| Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies | Q46756697 | ||
| Impact of patient weight on non-relapse mortality after marrow transplantation | Q47359135 | ||
| Outcomes after autologous SCT in lymphoma patients grouped by weight | Q47406671 | ||
| Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. | Q51822648 | ||
| Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft | Q73375202 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 617-618 | |
| P577 | publication date | 2015-03-02 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients. | |
| P478 | volume | 50 |
Search more.